论文部分内容阅读
目前晚期卵巢癌的治疗虽以手术为主,化疗也占重要位置。但两者的配合,以及手术时机的掌握,选择化疗方案及途径迄未统一。现就本院1985～1988年收治的41例晚期上皮性卵巢癌术后残存肿瘤大小与化疗的关系进行分析。1 临床资料 年龄34～66岁。临床分期为:Ⅱ期4例,Ⅲ期23例,Ⅳ期14例,病理分类:浆液性囊腺癌31例,粘液性囊腺癌7例,子宫内膜样癌2例,差分化腺癌1例。手术方式有5种:(1)仅行部分原发灶及转移灶切除4例。(2)行全子宫、双附件、大网膜、阑尾加部分转移肿瘤切除术25例。(3)术式(2)加盆、腹腔淋巴
Although the treatment of advanced ovarian cancer surgery, chemotherapy also occupies an important position. But with the cooperation of the two, as well as the timing of surgery, the choice of chemotherapy programs and approaches have not been unified. The hospital from 1985 to 1988 admitted 41 cases of advanced epithelial ovarian cancer residual tumor size and the relationship between chemotherapy were analyzed. 1 clinical data age 34 to 66 years old. The clinical stage was as follows: 4 cases in stage Ⅱ, 23 cases in stage Ⅲ and 14 cases in stage Ⅳ. Pathological classification included 31 cases of serous cystadenocarcinoma, 7 cases of mucinous cystadenocarcinoma, 2 cases of endometrioid carcinoma, 1 case. There are five kinds of surgical methods: (1) only partial primary tumor and metastatic resection in 4 cases. (2) line of uterus, double attachment, omentum, appendix and partial tumor resection in 25 cases. (3) surgery (2) plus basin, abdominal lymph